Enhanced NMDA receptor-mediated intracellular calcium signaling in magnocellular neurosecretory neurons in heart failure rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 305, Issue 4, 2013, Pages

  Stern, Javier E ^a   Potapenko, Evgeniy S ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Ca2+; Glutamate; NMDA; Supraoptic; Vasopressin

Indexed keywords

GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; AMINO ACID RECEPTOR STIMULATING AGENT; CALCIUM ION; N METHYL DEXTRO ASPARTIC ACID; N METHYLASPARTIC ACID; VASOPRESSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED RESPONSE; HEART CYCLE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; MAGNOCELLULAR NEUROSECRETORY CELL; MALE; MEMBRANE DEPOLARIZATION; NEUROHYPOPHYSIS; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL TISSUE; CALCIUM HOMEOSTASIS; GIANT CELL; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; INTRACELLULAR SIGNALING; MEMBRANE STEADY POTENTIAL; PATCH CLAMP; POSITIVE FEEDBACK; ACTION POTENTIAL; ANIMAL; CONFOCAL MICROSCOPY; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; FEEDBACK SYSTEM; HYPOTHALAMUS; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; SUPRAOPTIC; TIME; WISTAR RAT;

CA2+; GLUTAMATE; NMDA; SUPRAOPTIC; VASOPRESSIN;

ACTION POTENTIALS; ANIMALS; CALCIUM SIGNALING; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; FEEDBACK, PHYSIOLOGICAL; HEART FAILURE; HYPOTHALAMUS; MALE; MICROSCOPY, CONFOCAL; N-METHYLASPARTATE; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 84881638084     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00160.2013     Document Type: Article

References (73)

1. Armstrong WE, Wang L, Li C, Teruyama R. Performance, properties and plasticity of identified oxytocin and vasopressin neurones in vitro. J Neuroendocrinol 22: 330-342, 2010.
2. Arnolda L, McGrath BP, Cocks M, Johnston CI. Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit. J Clin Invest 78: 674-679, 1986.
3. Bains JS, Ferguson AV. Nitric oxide regulates NMDA-driven GABAe-rgic inputs to type I neurones of the rat paraventricular nucleus. J Physiol 499: 733-746, 1997.
4. Biancardi VC, Son SJ, Sonner PM, Zheng H, Patel KP, Stern JE. Contribution of central nervous system endothelial nitric oxide synthase to neurohumoral activation in heart failure rats. Hypertension 58: 454-463, 2011.
5. Botta P, de Souza FM, Sangrey T, de Schutter E, Valenzuela CF. Alcohol excites cerebellar Golgi cells by inhibiting the Na+/K+ ATPase. Neuropsychopharmacology 35: 1984-1996, 2010.
6. Cazalis M, Dayanithi G, Nordmann JJ. The role of patterned burst and interburst interval on the excitation-coupling mechanism in the isolated rat neural lobe. J Physiol 369: 45-60, 1985.
7. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819-823, 1984.
8. Colbran RJ, Brown AM. Calcium/calmodulin-dependent protein kinase II and synaptic plasticity. Curr Opin Neurobiol 14: 318-327, 2004.
9. Creager MA, Faxon DP, Cutler SS, Kohlmann O, Ryan TJ, Gavras H. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. J Am Coll Cardiol 7: 758-765, 1986.
10. Dayanithi G, Forostyak O, Ueta Y, Verkhratsky A, Toescu EC. Segregation of calcium signalling mechanisms in magnocellular neurones and terminals. Cell Calcium 51: 293-299, 2012.
11. de Kock CP, Burnashev N, Lodder JC, Mansvelder HD, Brussaard AB. NMDA receptors induce somatodendritic secretion in hypothalamic neurones of lactating female rats. J Physiol 561: 53-64, 2004.
12. Emptage N, Bliss TV, Fine A. Single synaptic events evoke NMDA receptor-mediated release of calcium from internal stores in hippocampal dendritic spines. Neuron 22: 115-124, 1999.
13. Filosa JA, Naskar K, Perfume G, Iddings JA, Biancardi VC, Vatta MS, Stern JE. Endothelin-mediated calcium responses in supraoptic nucleus astrocytes influence magnocellular neurosecretory firing activity. J Neuroendocrinol 24: 378-392, 2012.
14. Finley JJT, Konstam MA, Udelson JE. Arginine vasopressin antagonists for the treatment of heart failure and hyponatremia. Circulation 118: 410-421, 2008.
15. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82: 1724-1729, 1990.
16. Ghamari-Langroudi M, Bourque CW. Flufenamic acid blocks depolarizing afterpotentials and phasic firing in rat supraoptic neurones. J Physiol 545: 537-542, 2002.
17. Goldsmith SR, Francis GS, Cowley AW. Arginine vasopressin and the renal response to water loading in congestive heart failure. Am J Cardiol 58: 295-299, 1986.
18. Goldsmith SR, Francis GS, Cowley AW, Goldenberg IF, Cohn JN. Hemodynamic effects of infused arginine vasopressin in congestive heart failure. J Am Coll Cardiol 8: 779-783, 1986.
19. Goldsmith SR, Francis GS, Cowley AW, Levine TB, Cohn JN. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol 1: 1385-1390, 1983.
20. Gouzenes L, Desarmenien MG, Hussy N, Richard P, Moos FC. Vasopressin regularizes the phasic firing pattern of rat hypothalamic magnocellular vasopressin neurons. J Neurosci 18: 1879-1885, 1998.
21. Greffrath W, Martin E, Reuss S, Boehmer G. Components of after-hyperpolarization in magnocellular neurones of the rat supraoptic nucleus in vitro. J Physiol 513: 493-506, 1998.
22. Guggilam A, Haque M, Kerut EK, McIlwain E, Lucchesi P, Seghal I, Francis J. TNF-a blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. Am J Physiol Heart Circ Physiol 293: H599-H609, 2007.
23. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 7: 335-346, 2006.
24. Han TH, Lee K, Park JB, Ahn D, Park JH, Kim DY, Stern JE, Lee SY, Ryu PD. Reduction in synaptic GABA release contributes to target-selective elevation of PVN neuronal activity in rats with myocardial infarction. Am J Physiol Regul Integr Comp Physiol 299: R129-R139, 2010.
25. Hu B, Bourque CW. NMDA receptor-mediated rhythmic bursting activity in rat supraoptic nucleus neurones in vitro. J Physiol 458: 667-687, 1992.
26. Infanger DW, Cao X, Butler SD, Burmeister MA, Zhou Y, Stupinski JA, Sharma RV, Davisson RL. Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ Res 106: 1763-1774, 2010.
27. Kang YM, He RL, Yang LM, Qin DN, Guggilam A, Elks C, Yan N, Guo Z, Francis J. Brain tumour necrosis factor-alpha modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure. Cardiovasc Res 83: 737-746, 2009.
28. 2+ exchangers in the rat supraoptic magnocellular neuron is polarized to axon terminals. J Neurosci 23: 11673-11680, 2003.
29. Kleiber AC, Zheng H, Schultz HD, Peuler JD, Patel KP. Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure. Am J Physiol Regul Integr Comp Physiol 294: R1863-R1872, 2008.
30. Komori Y, Tanaka M, Kuba M, Ishii M, Abe M, Kitamura N, Verkhratsky A, Shibuya I, Dayanithi G. Ca(2+) homeostasis, Ca(2+) signalling and somatodendritic vasopressin release in adult rat supraoptic nucleus neurones. Cell Calcium 48: 324-332, 2010.
31. Li DP, Yang Q, Pan HM, Pan HL. Pre- and postsynaptic plasticity underlying augmented glutamatergic inputs to hypothalamic presympa-thetic neurons in spontaneously hypertensive rats. J Physiol 586: 1637-1647, 2008.
32. Li YF, Cornish KG, Patel KP. Alteration of NMDA NR1 receptors within the paraventricular nucleus of hypothalamus in rats with heart failure. Circ Res 93: 990-997, 2003.
33. Ludwig M, Leng G. Autoinhibition of supraoptic nucleus vasopressin neurons in vivo: a combined retrodialysis/electrophysiological study in rats. Eur J Neurosci 9: 2532-2540, 1997.
34. Ludwig M, Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci 7: 126-136, 2006.
35. Lytton J, Westlin M, Hanley MR. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 266: 17067-17071, 1991.
36. Malenka RC, Kauer JA, Perkel DJ, Nicoll RA. The impact of postsynaptic calcium on synaptic transmission-its role in long-term potentiation. Trends Neurosci 12: 444-450, 1989.
37. Mancia G. Sympathetic activation in congestive heart failure. Eur Heart J 11, Suppl A: 3-11, 1990.
38. McBain CJ, Mayer ML. N -methyl-D-aspartic acid receptor structure and function. Physiol Rev 74: 723-760, 1994.
39. Mrejeru A, Wei A, Ramirez JM. Calcium-activated non-selective cation currents are involved in generation of tonic and bursting activity in dopamine neurons of the substantia nigra pars compacta. J Physiol 589: 2497-2514, 2011.
40. Nakamura Y, Haneda T, Osaki J, Miyata S, Kikuchi K. Hypertrophic growth of cultured neonatal rat heart cells mediated by vasopressin V(1A) receptor. Eur J Pharmacol 391: 39-48, 2000.
41. Nicod P, Waeber B, Bussien JP, Goy JJ, Turini G, Nussberger J, Hofbauer KG, Brunner HR. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure. Am J Cardiol 55: 1043-1047, 1985.
42. Nissen R, Hu B, Renaud LP. Regulation of spontaneous phasic firing of rat supraoptic vasopressin neurones in vivo by glutamate receptors. J Physiol 484: 415-424, 1995.
43. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77: 721-730, 1988.
44. Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin ML. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation 75: IV80-IV92, 1987.
45. Paschen W, Doutheil J, Gissel C, Treiman M. Depletion of neuronal endoplasmic reticulum calcium stores by thapsigargin: effect on protein synthesis. J Neurochem 67: 1735-1743, 1996.
46. Peng TI, Greenamyre JT. Privileged access to mitochondria of calcium influx through N-methyl-D-aspartate receptors. Mol Pharmacol 53: 974-980, 1998.
47. Petersen OH. Cation channels: homing in on the elusive CAN channels. Curr Biol 12: R520-R522, 2002.
48. Potapenko ES, Biancardi VC, Florschutz RM, Ryu PD, Stern JE. Inhibitory-excitatory synaptic balance is shifted toward increased excitation in magnocellular neurosecretory cells of heart failure rats. J Neuro-physiol 106: 1545-1557, 2011.
49. Potapenko ES, Biancardi VC, Zhou Y, Stern JE. Altered astrocyte glutamate trasporter regulation of hypothalamic neurosecretory neurons in heart failure rats. Am J Physiol Regul Integr Comp Physiol 303: R291-R300, 2012.
50. Potapenko ES, Biancardi VC, Zhou Y, Stern JE. Astrocytes modulate a postsynaptic NMDA-GABAA-receptor crosstalk in hypothalamic neurosecretory neurons. J Neurosci 33: 631-640, 2013.
51. Poulain DA, Wakerley JB. Electrophysiology of hypothalamic magnocellular neurones secreting oxytocin and vasopressin. Neuroscience 7: 773-808, 1982.
52. Riegger GA, Liebau G, Bauer E, Kochsiek K. Vasopressin and renin in high output heart failure of rats: hemodynamic effects of elevated plasma hormone levels. J Cardiovasc Pharmacol 7: 1-5, 1985.
53. Rouleau JL, Packer M, Moye L, de Champlain J, Bichet D, Klein M, Rouleau JR, Sussex B, Arnold JM, Sestier F, Parker JO, McEwan P, Bernstein V, Cuddy TE, Lamas G, Gottlieb SS, McCans J, Nadeau C, Delage F, Wun CC, Pfeffer MA. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol 24: 583-591, 1994.
54. Sah P, Faber ES. Channels underlying neuronal calcium-activated potassium currents. Prog Neurobiol 66: 345-353, 2002.
55. Son SJ, Stern JE. Locally released vasopressin increases presympathetic PVN neuronal activity. FASEB J 22: 918-952, 2008.
56. Sonner PM, Filosa JA, Stern JE. Diminished A-type potassium current and altered firing properties in presympathetic PVN neurones in renovascular hypertensive rats. J Physiol 586: 1605-1622, 2008.
57. Sonner PM, Lee S, Ryu PD, Lee SY, Stern JE. Imbalanced K+ and Ca2+ subthreshold interactions contribute to increased hypothalamic presympathetic neuronal excitability in hypertensive rats. J Physiol 589: 667-683, 2011.
58. Stern JE. Electrophysiological and morphological properties of pre-autonomic neurones in the rat hypothalamic paraventricular nucleus. J Physiol 537: 161-177, 2001.
59. Stern JE, Armstrong WE. Electrophysiological differences between oxytocin and vasopressin neurones recorded from female rats in vitro. J Physiol 488: 701-708, 1995.
60. Swanson LW, Sawchenko PE. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocri-nology 31: 410-417, 1980.
61. Swenson KL, Badre SE, Morsette DJ, Sladek CD. N-methyl-D-aspartic acid stimulation of vasopressin release: role in osmotic regulation and modulation by gonadal steroids. J Neuroendocrinol 10: 679-685, 1998.
62. Szatalowicz VL, Arnold PE, Chaimovitz C, Bichet D, Berl T, Schrier RW. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med 305: 263-266, 1981.
63. Teruyama R, Armstrong WE. Calcium-dependent fast depolarizing afterpotentials in vasopressin neurons in the rat supraoptic nucleus. J Neurophysiol 98: 2612-2621, 2007.
64. Teruyama R, Armstrong WE. Enhancement of calcium-dependent af-terpotentials in oxytocin neurons of the rat supraoptic nucleus during lactation. J Physiol 566: 505-518, 2005.
65. Teruyama R, Sakuraba M, Kurotaki H, Armstrong WE. Transient receptor potential channel m4 and m5 in magnocellular cells in rat supraoptic and paraventricular nuclei. J Neuroendocrinol 23: 1204-1213, 2011.
66. Toescu EC, Verkhratsky A. Principles of Calcium Signalling. New York: Plenum, 1998.
67. Ueta Y, Fujihara H, Serino R, Dayanithi G, Ozawa H, Matsuda K-I, Kawata M, Yamada J, Ueno S, Fukuda A, Murphy D. Transgenic expression of enhanced green fluorescent protein enables direct visualization for physiological studies of vasopressin neurons and isolated nerve terminals of the rat. Endocrinology 146: 406-413, 2005.
68. Zhang K, Li YF, Patel KP. Blunted nitric oxide-mediated inhibition of renal nerve discharge within PVN of rats with heart failure. Am J Physiol Heart Circ Physiol 281: H995-H1004, 2001.
69. Zhang K, Li YF, Patel KP. Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure. Am J Physiol Regul Integr Comp Physiol 282: R1006-R1015, 2002.
70. Zheng H, Li YF, Cornish KG, Zucker IH, Patel KP. Exercise training improves endogenous nitric oxide mechanisms within the paraventricular nucleus in rats with heart failure. Am J Physiol Heart Circ Physiol 288: H2332-H2341, 2005.
71. Zheng H, Liu X, Li Y, Sharma NM, Patel KP. Gene transfer of neuronal nitric oxide synthase to the paraventricular nucleus reduces the enhanced glutamatergic tone in rats with chronic heart failure. Hypertension 58: 966-973, 2011.
72. Ziegler DR, Cullinan WE, Herman JP. Organization and regulation of paraventricular nucleus glutamate signaling systems: N-methyl-D-aspar-tate receptors. J Comp Neurol 484: 43-56, 2005.
73. Zucker IH, Schultz HD, Li YF, Wang Y, Wang W, Patel KP. The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide. Prog Biophys Mol Biol 84: 217-232, 2004.